Development of Vi conjugate – a new generation of typhoid vaccine

Sir Almroth Wright: pioneer immunologist

(2014) Harold Ellis   BRITISH JOURNAL OF HOSPITAL MEDICINE

Prospects for prevention of Salmonella infection in children through vaccination

(2013) Alastair C. McGregor et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5–7 September 2012

(2013) Chris Jones et al.   VACCINE

A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned

(2013) Shousun C. Szu et al.   VACCINE

A scalable method for O-antigen purification applied to various Salmonella serovars

(2012) F. Micoli et al.   ANALYTICAL BIOCHEMISTRY

Vaccination and herd immunity

(2012) Harunor Rashid et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa

(2012) Nicholas A Feasey et al.   LANCET

A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi

(2012) Ying-Jie Lu et al.   VACCINE

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan

(2012) M. Imran Khan et al.   VACCINE

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

(2012) Nick J. Andrews et al.   VACCINE

Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM197 glycoconjugate vaccine against Salmonella Typhi

(2012) Simona Rondini et al.   Journal of Infection in Developing Countries

Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites

(2011) Karen Keddy et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

(2011) Vu Dinh Thiem et al.   Clinical and Vaccine Immunology

Salmonella enterica Serovar Enteritidis Core O Polysaccharide Conjugated to H:g,m Flagellin as a Candidate Vaccine for Protection against Invasive Infection withS.Enteritidis

(2011) Raphael Simon et al.   INFECTION AND IMMUNITY

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults

(2011) Pierre van Damme et al.   PLoS One

Coalition against Typhoid (CaT): A new, global initiative to advance typhoid vaccination

(2011) Christopher B. Nelson et al.   VACCINE

Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine

(2011) So Jung An et al.   VACCINE

Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi

(2011) F. Micoli et al.   VACCINE

Development of a Bead Immunoassay To Measure Vi Polysaccharide-Specific Serum IgG after Vaccination with the Salmonella enterica Serovar Typhi Vi Polysaccharide

(2010) H. F. Staats et al.   Clinical and Vaccine Immunology

Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD− S. Typhi-specific IgA and IgG B memory cells in humans

(2010) Rezwanul Wahid et al.   CLINICAL IMMUNOLOGY

Population impact of Vi capsular polysaccharide vaccine

(2010) M Imran Khan et al.   Expert Review of Vaccines

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination

(2010) H.J. Adam et al.   VACCINE

Global Trends in Typhoid and Paratyphoid Fever

(2009) John A. Crump et al.   CLINICAL INFECTIOUS DISEASES

Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement

(2009) Coenraad FM Hendriksen   Expert Review of Vaccines

A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in India

(2009) Dipika Sur et al.   NEW ENGLAND JOURNAL OF MEDICINE

An optimization model for reducing typhoid cases in developing countries without increasing public spending

(2009) Donald T. Lauria et al.   VACCINE

a study of typhoid fever in five Asian countries: disease burden and implications for controls

(2008) R Leon Ochiai   BULLETIN OF THE WORLD HEALTH ORGANIZATION